Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Ionis Pharmaceuticals's Donidalorsen Sodium?
Donidalorsen Sodium is an antisense oligonucleotide commercialized by Ionis Pharmaceuticals, with a leading Phase III program in Hereditary Angioedema (HAE)...
Data Insights
Risk adjusted net present value: What is the current valuation of Ionis Pharmaceuticals's Donidalorsen Sodium?
Donidalorsen Sodium is an antisense oligonucleotide commercialized by Ionis Pharmaceuticals, with a leading Phase III program in Hereditary Angioedema (HAE)...